{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:17Z","timestamp":1790746697870,"version":"4.1.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"52","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,27]]},"DOI":"10.18632\/oncotarget.13521","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T17:50:44Z","timestamp":1479923444000},"page":"86985-86998","source":"Crossref","is-referenced-by-count":22,"title":["Hepatocyte specific expression of an oncogenic variant of \u03b2-catenin results in cholestatic liver disease"],"prefix":"10.18632","volume":"7","author":[{"given":"Ursula J.","family":"Lemberger","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, Medical University of Vienna, Vienna, Austria"},{"name":"Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria"},{"name":"Hans Popper Laboratory for Molecular Hepatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Hans Popper Laboratory for Molecular Hepatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Karer","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Haas","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Stojakovic","sequence":"additional","affiliation":[{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sch\u00f6fer","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Ulrich","family":"Marschall","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Wrba","sequence":"additional","affiliation":[{"name":"Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto M.","family":"Taketo","sequence":"additional","affiliation":[{"name":"Division of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Egger","sequence":"additional","affiliation":[{"name":"Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[{"name":"Hans Popper Laboratory for Molecular Hepatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"\u00d6sterreicher","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Nusse","year":"2012","journal-title":"Cell"},{"key":"2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/hep.21154","article-title":"Role of \u03b2-catenin in the adult liver","volume":"43","author":"Gonzalez","year":"2006","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Birchmeier","year":"2008","journal-title":"Nature reviews Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.148.3.567","article-title":"Requirement for beta-catenin in anterior-posterior axis formation in mice","volume":"148","author":"Birchmeier","year":"2000","journal-title":"The Journal of cell biology"},{"key":"5","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1101\/gad.1686208","article-title":"Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of -catenin in mice","volume":"22","author":"Birchmeier","year":"2008","journal-title":"Genes Dev"},{"key":"6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2003.12.047","article-title":"\u03b2-Catenin is temporally regulated during normal liver development\u22c6","volume":"126","author":"Monga","year":"2004","journal-title":"Gastroenterology"},{"key":"7","first-page":"2316","article-title":"Liver Zonation Occurs Through a \u03b2-Catenin-Dependent, c-Myc\u2013Independent Mechanism","volume":"136","author":"Tosh","year":"2009","journal-title":"YGAST"},{"key":"8","first-page":"660","article-title":"Convergence of Wnt Signaling on the HNF4\u03b1-Driven Transcription in Controlling Liver Zonation","volume":"137","author":"Amicone","year":"2009","journal-title":"YGAST"},{"key":"9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2006.08.042","article-title":"Conditional Deletion of \u03b2-Catenin Reveals Its Role in Liver Growth and Regeneration","volume":"131","author":"Monga","year":"2006","journal-title":"Gastroenterology"},{"key":"10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/hep.26924","article-title":"T-cell factor 4 and beta-catenin chromatin occupancies pattern zonal liver metabolism in mice","volume":"59","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23801","article-title":"Liver-specific \u03b2-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis","volume":"52","author":"Behari","year":"2010","journal-title":"Hepatology"},{"key":"12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbadis.2010.12.021","article-title":"Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease","volume":"1812","author":"Trauner","year":"2011","journal-title":"Biochimica et biophysica acta"},{"key":"13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/dmd.113.056358","article-title":"The role of canalicular ABC transporters in cholestasis","volume":"42","author":"Trauner","year":"2014","journal-title":"Drug metabolism and disposition"},{"key":"14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.21523","article-title":"Liver-specific loss of \u03b2-catenin results in delayed hepatocyte proliferation after partial hepatectomy","volume":"45","author":"Hebrok","year":"2007","journal-title":"Hepatology"},{"key":"15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.23538","article-title":"Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant \u03b2-catenin","volume":"51","author":"Monga","year":"2010","journal-title":"Hepatology"},{"key":"16","first-page":"744","article-title":"Liver-Specific \u00ce-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced Steatohepatitis","volume":"176","author":"Monga","year":"2010","journal-title":"AJPA"},{"key":"17","first-page":"754","article-title":"\u03b2-Catenin Regulates Hepatic Mitochondrial Function and Energy Balance in Mice","volume":"143","author":"Sylvester","year":"2012","journal-title":"YGAST"},{"key":"18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24766","article-title":"\u03b2-Catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice","volume":"55","author":"Behari","year":"2012","journal-title":"Hepatology"},{"key":"19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21131","article-title":"Liver-specific loss of \u03b2-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice","volume":"43","author":"Hebrok","year":"2006","journal-title":"Hepatology (Baltimore, Md)"},{"key":"20","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"Perret","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"21","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/sj.onc.1202858","article-title":"Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis","volume":"18","author":"Barrett","year":"1999","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/j.gastro.2004.02.014","article-title":"Disruption of \u03b2-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice","volume":"126","author":"Thorgeirsson","year":"2004","journal-title":"Gastroenterology"},{"key":"23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2005.01.029","article-title":"Activation of the canonical Wnt\/\u03b2-catenin pathway confers growth advantages in c-Myc\/E2F1 transgenic mouse model of liver cancer","volume":"42","author":"Thorgeirsson","year":"2005","journal-title":"Journal of Hepatology"},{"key":"24","first-page":"821","article-title":"Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene","volume":"49","author":"Monga","year":"2008","journal-title":"Hepatology"},{"key":"25","first-page":"2085","article-title":"Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade","volume":"61","author":"Thorgeirsson","year":"2001","journal-title":"Cancer research"},{"key":"26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Chevet","year":"2012","journal-title":"Nature Genetics"},{"key":"27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"beta-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"28","first-page":"1971","article-title":"Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin","volume":"62","author":"Taketo","year":"2002","journal-title":"Cancer research"},{"key":"29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","article-title":"Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations","volume":"64","author":"Taketo","year":"2004","journal-title":"Cancer research"},{"key":"30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.23747","article-title":"Conditional \u03b2-catenin loss in mice promotes chemical hepatocarcinogenesis: Role of oxidative stress and platelet-derived growth factor receptor \u03b1\/phosphoinositide 3-kinase signaling","volume":"52","author":"Monga","year":"2010","journal-title":"Hepatology"},{"key":"31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Trauner","year":"2013","journal-title":"J Hepatol"},{"key":"32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap\u2014bile acids in metabolic control","volume":"10","author":"Groen","year":"2014","journal-title":"Nature reviews Endocrinology"},{"key":"33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Jansen","year":"2014","journal-title":"Nature reviews Gastroenterology & hepatology"},{"key":"34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Schoonjans","year":"2008","journal-title":"Nature reviews Drug discovery"},{"key":"35","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"Journal of lipid research"},{"key":"36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/dvg.20568","article-title":"Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies","volume":"47","author":"Schmidt","year":"2009","journal-title":"Genesis"},{"key":"37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2353\/ajpath.2010.090300","article-title":"Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence","volume":"176","author":"Mikulits","year":"2010","journal-title":"Am J Pathol"},{"key":"38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/path.2169","article-title":"Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations","volume":"212","author":"Terris","year":"2007","journal-title":"The Journal of pathology"},{"key":"39","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1073\/pnas.0404761101","article-title":"Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas","volume":"101","author":"Perret","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"40","first-page":"239","article-title":"A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors","volume":"26","author":"Schwarz","year":"2005","journal-title":"Carcinogenesis"},{"key":"41","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.18632\/oncotarget.2899","article-title":"Farnesoid X receptor associates with beta-catenin and inhibits its activity in hepatocellular carcinoma","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V","article-title":"DNA excision in liver by an albumin-Cre transgene occurs progressively with age","volume":"26","author":"Magnuson","year":"2000","journal-title":"Genesis"},{"key":"43","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1093\/emboj\/18.21.5931","article-title":"Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene","volume":"18","author":"Taketo","year":"1999","journal-title":"The EMBO Journal"},{"key":"44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/gene.20039","article-title":"Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse","volume":"39","author":"Metzger","year":"2004","journal-title":"Genesis"},{"key":"45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.25601","article-title":"Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice","volume":"56","author":"Trauner","year":"2012","journal-title":"Hepatology"},{"key":"46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.26732","article-title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia","volume":"59","author":"Trauner","year":"2014","journal-title":"Hepatology"},{"key":"47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"Brenner","year":"2009","journal-title":"Hepatology"},{"key":"48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.1017547108","article-title":"Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver","volume":"108","author":"Brenner","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.25542","article-title":"Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver","volume":"121","author":"Trauner","year":"2001","journal-title":"Gastroenterology"},{"key":"50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Jaeschke","year":"2006","journal-title":"Gastroenterology"},{"key":"51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","article-title":"Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation","volume":"22","author":"Backhed","year":"2015","journal-title":"Cell metabolism"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:46:10Z","timestamp":1749761170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":51,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016,12,27]]}},"alternative-id":["13521","27895309"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13521","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}